Anticoagulation for cardioversion of atrial arrhythmias

We would advocate 3 weeks of anticoagulation prior to, and 4 weeks post-cardioversion (either electrical or chemical) for patients in chronic atrial fibrillation or flutter. In selected cases it seems reasonable to use transoesophageal echocardiography to exclude preformed thrombus and negate the ne...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European heart journal 1998-04, Vol.19 (4), p.548-552
Hauptverfasser:	Mayet, J., More, R.S., Sutton, G.C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Anticoagulants - administration & dosage anticoagulation atrial fibrillation Atrial Fibrillation - drug therapy Atrial Fibrillation - therapy atrial flutter Biological and medical sciences Blood. Blood coagulation. Reticuloendothelial system cardioversion Chronic Disease Electric Countershock - adverse effects Female Humans Male Medical sciences Pharmacology. Drug treatments Randomized Controlled Trials as Topic supraventricular tachycardia Thromboembolism - etiology Thromboembolism - prevention & control Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!